ArticleSkin Lesions in Patients Treated With Imatinib Mesylate: A 5-Year Prospective StudyAuthor:Dario Didona, MD Publish date: June 7, 2016Imatinib mesylate (IM) represents the first-line treatment of patients with chronic myeloid leukemia (CLM) or gastrointestinal stromal tumor (GIST)... Read More